Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As weight loss medications like Ozempic continue to gain traction for their ...

LONDON, Nov 7 — Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

New research suggests that Ozempic may be a helpful treatment for knee pain caused by osteoarthritis. Here’s what you need to know.

Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most ...

“I’m playing doctor,” Bookless said, describing her foray into the world of do-it-yourself GLP-1 medication, injections ...

Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its ... In a phase 2 trial of the same drug ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

Weight loss injections can significantly ease arthritis symptoms in people struggling with obesity, a new study has shown.

Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making ...